Open AccessBCG as an adjunct or alternative vaccine to prevent COVID-19?
Author(s) -
ChienHsiang Weng,
Philip A. Chan
Publication year - 2020
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/taaa175
Subject(s) - medicine , vaccination , covid-19 , adjunct , immunology , immunity , immune system , virology , bcg vaccine , outbreak , infectious disease (medical specialty) , disease , linguistics , philosophy
BCG vaccine may enhance the innate immune response as well as induce a specific immunity against SARS-CoV-2, which may potentially be associated with reduced severity of COVID-19, and may or may not necessarily be protective against SARS-CoV-2 infection. The effect from BCG vaccine was observed even decades after the vaccination.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom